Stay informed with the latest litigation news. Explore now

IP Verse

Biogen competitive analysis

Latest publications and patents of Biogen New

Explore the latest publications and patents granted to Biogen, showcasing their recent innovations and technological advancements.

Last updated on: Sep 7, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Biogen

EP3490653
Aug 27, 2025Implantable Intraventricular Sampling And Infusion Access DeviceGranted And Under Opposition
EP4601637
Aug 20, 2025Glycogen Synthase Kinase 3 Inhibitors And Uses ThereofPending
EP4351643
Aug 6, 2025Methods For Treating Alzheimer'S DiseasePending
EP4051679
Aug 6, 2025Condensed Pyridazine Or Pyrimidine As Btk InhibitorsGranted
EP4281550
Jul 23, 2025Microtubule Destabilizer Additives To Increase Recombinant Viral Vector TitersPending
EP4181780
Jul 16, 2025Fluid Catheter Device For Recording Brain StateGranted And Under Opposition
EP4582099
Jul 9, 2025Methods Of Treating Inflammatory And Autoimmune Diseases With NatalizumabPending
EP4524571
Jun 11, 2025Assay For Jc Virus AntibodiesPending
EP4562018
Jun 4, 2025Compounds For Treating Huntington'S DiseasePending
EP4558481
May 28, 2025Emopamil-Binding Protein Inhibitors And Uses ThereofPending

Latest oppositions filed by Biogen

Explore patent oppositions filed by Biogen against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 11, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3403646
Liquid Pharmaceutical CompositionFRESENIUS KABI DEUTSCHLANDOct 5, 2022
EP3145488
Liquid Pharmaceutical CompositionARES TRADINGJul 22, 2020
EP3212667
Pharmaceutical Anti-Tnf-Alpha Antibody FormulationRICHTER GEDEON NYRTJun 19, 2019
EP3148510
Liquid Pharmaceutical CompositionARES TRADINGMar 26, 2019

Latest patents of Biogen opposed by its competitors

Explore Biogen's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 11, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2645106
Oct 2, 2024Methods And Products For Evaluating An Immune Response To A Therapeutic Agent1
EP3036320
Apr 3, 2024Control Of Protein Glycosylation By Culture Medium Supplementation And Cell Culture Process Parameters1
EP2956477
Jan 24, 2024Optimized Factor Viii Gene1
EP3999643
Nov 22, 2023Methods Of Treating Or Preventing Spinal Muscular Atrophy5
EP2701778
Oct 18, 2023A Limiter For A Dispensing Device2
EP2972238
Apr 26, 2023Use Of Raman Spectroscopy To Monitor Culture Medium2
EP3339865
Dec 14, 2022Assay For Jc Virus Antibodies1
EP3575792
Nov 30, 2022Method Of Assessing Risk Of Pml2
EP2653873
Aug 24, 2022Compositions And Uses For Treating Multiple Sclerosis14
EP3122869
Aug 10, 2022Methods For Overcoming Glutamine Deprivation During Mammalian Cell Culture1

Latest PTAB cases involving Biogen New

Discover the latest PTAB cases involving Biogen, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 13, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Biogen

PGR2022-00054Jul 29, 2022SANDOZBIOGEN MAInstitution Denied
IPR2019-00789Mar 5, 2019SAWAI USABIOGEN MATerminated
IPR2018-01403Jul 13, 2018MYLAN PHARMACEUTICALSBIOGEN MATerminated
IPR2018-00285Dec 14, 2017PFIZERBIOGENTerminated-Settled
IPR2018-00231Dec 1, 2017PFIZERBIOGENTerminated
IPR2018-00186Dec 1, 2017PFIZERBIOGENTerminated-Settled
IPR2018-00086Nov 2, 2017PFIZERBIOGENInstitution Denied
IPR2017-01168Apr 28, 2017PFIZERBIOGENFinal Written Decision
IPR2017-01167Apr 27, 2017PFIZERBIOGENInstitution Denied
IPR2017-01166Apr 21, 2017PFIZERBIOGENInstitution Denied

Top competitors of Biogen

Top competitors of Biogen based on patent oppositions.